Califia Bio Inc
Califia Bio Inc. is collaborating with several NIH-funded academic research groups to develop treatments for unmet therapeutic needs in the areas of neurodegenerative disease, inflammation and organ failure. Califia Bio is currently developing two series of mixed lineage kinase (MLK3) inhibitors for potential treatment of HIV-Associated Neurocognitive Disorder (HAND), Parkinson’s Disease and Heart Failure. We are exploring the development of inhibitors of dual leucine zipper kinase (DLK) as potential treatments for glaucoma and other neuropathic disorders. Califia Bio’s expertise is in hit generation, lead optimization and preclinical development. We have partnered with world-class academic biology groups to bring important discoveries to the clinic.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
1
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Califia Bio Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
Showing 1 of 2 verified contacts
Top roles at Califia Bio Inc
2 distinct titles indexed · top 2 shown.
- 1ceo
- 1js
Sign up to unlock all 2 contacts at Califia Bio Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Califia Bio Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.